Complete Company Report + Documents
- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
MCA Documents Access
- Public filings
- Bulk ZIP download
- Dashboard access (1 year)
₹300
₹149
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Key Metrics
AUTHORISED CAPITAL
25.00 cr
PAID-UP CAPITAL
12.68 cr
COMPANY AGE
45 Years 10 Months
since 1980-07-24
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-07-26
OPEN CHARGES
1
-31.62 cr
SATISFIED CHARGES
17
31.62 cr
ACTIVE GST
2
Updated: 2025-03-08 17:02:58
Company Health Scores
Health scores for Grouppharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
Login to view scores
Vendor trust, compliance, financial health & director risk - with the reasons behind each score.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings.
View report →
About Grouppharma
Grouppharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24239MH1980PLC022889). Business overview includes Pharma (Drug Formulation & Development), incorporated on July 24, 1980 (46+ years old), headquartered in Thane, Maharashtra, India. The company is currently Active with Active Compliant compliance status. For FY 2024, the company reported revenue of ₹153.20 Cr with a profit of ₹9.96 Cr. It has 9 active directors. The company employs approximately 739 people.
Drug Formulation & Development
- Location W-46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra - 401506
- Website grouppharma.in
Name History
CIN / LLPINU24239MH1980PLC022889
Company No.022889
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date1980-07-24
Date of AGM2025-07-26
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Mumbai
PAN
LEI Number
Active ComplianceActive Compliant
Financial Performance of Grouppharma
Revenue Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▲ 38.3%
Growth (3 Year) ▼ -9.9%
Profit/Loss Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▼ 65.1%
Growth (3 Year) ▼ 60.7%
Values are in Mixed (K, L, Cr)
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,20,083.04 cr | 2,35,431.21 cr | 2,51,890.00 cr | 2,18,400.00 cr | 1,95,200.00 cr | 1,72,000.00 cr | 1,59,000.00 cr |
| Profit/Loss | 13,969.70 cr | 4,810.00 cr | 12,200.00 cr | 9,100.00 cr | -8,200.00 cr | 3,200.00 cr | 5,100.00 cr |
| Cash & Bank Balance | 38,200.00 cr | 35,100.00 cr | 32,000.00 cr | 28,500.00 cr | 25,200.00 cr | 22,000.00 cr | 19,800.00 cr |
| Net Worth | 1,26,731.94 cr | 1,37,500.00 cr | 1,40,200.00 cr | 1,28,000.00 cr | 1,15,000.00 cr | 1,02,000.00 cr | 95,000.00 cr |
| EBITDA | 27,865.49 cr | 29,800.00 cr | 30,200.00 cr | 27,000.00 cr | 24,500.00 cr | 22,000.00 cr | 20,100.00 cr |
Financial Ratios
■ Revenue ■ P/L ■ EBITDA
Values in Crores (Cr) - illustrative trend
FY 2021 - FY 2025
Key Insights (FY 2025)
Revenue2,20,083.04 cr ▼ 6.5%
Profit/Loss13,969.70 cr ▲ 190.6%
EBITDA27,865.49 cr
Net Profit Margin10.54%
Debt/Equity0.47
Current Ratio0.88
Return on Equity12.3%
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Profit Margin | 10.54 | 3.20 | 2.10 | 1.80 | 0.50 |
| Debt to EBITDA | 2.14 | 1.90 | 1.70 | 1.50 | 1.20 |
| Interest Coverage Ratio | 0.47 | 0.50 | 0.45 | 0.40 | 0.35 |
| Debt to Equity | 0.88 | 0.90 | 0.85 | 0.80 | 0.75 |
| Return on Equity | 12.10 | 3.00 | 2.00 | 1.50 | 0.20 |
| Current Ratio | 1.20 | 1.15 | 1.10 | 1.05 | 0.99 |
| Quick Ratio | 0.95 | 0.92 | 0.88 | 0.85 | 0.80 |
| EBITDA Margin | 12.00 | 10.00 | 8.00 | 7.00 | 5.00 |
| Return on Capital Employed | 8.00 | 2.00 | 1.00 | 0.20 | 0.00 |
| Earning Per Share | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPFO Establishments (1)
MRNOI0019835000
Closed/All Member Excluded
StatusCode No Allotted Was Before Online Registration Started.
ActivityPaper
StateUttar Pradesh
Coverage07-JUN-1995
Current Directors (9)
Charges Overview
Others : 36.25 cr
Central Bank Of India : 5.50 cr
Open Charges: 1
Satisfied Charges: 17
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 28 Oct 2025
|
20.00 cr | Open |
|
Others
Creation Date: 04 Mar 2005
|
16.25 cr | Closed |
|
Central Bank Of India
Creation Date: 27 Mar 2002
|
5.50 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases
District Court
Cases Found
High Court
Cases Found
Supreme Court
Cases Found
NCLT
Cases Found
NCLAT
Cases Found
View Details →
Frequently Asked Questions about Grouppharma
What is CIN of Grouppharma?
The Corporate Identification Number (CIN) for Grouppharma is U24239MH1980PLC022889. CIN is a distinct identification code allotted by the Registrar of Companies (ROC) under the Ministry of Corporate Affairs (MCA). The company registration number is 022889 as per MCA.
When was Grouppharma incorporated?
Grouppharma was incorporated 45 years 10 months ago on 24 Jul 1980.
What is paid-up capital and authorised share capital of Grouppharma?
The paid-up capital of Grouppharma is ₹ 126,839,500.00 and authorised share capital is ₹ 250,000,000.00.
Who are the current board members and directors of Grouppharma?
Currently 8 directors are associated with Grouppharma: Deepak Mohan, Sunil Attavar Cajaten, Ann Valerie Sunil Attavar, Srinivas Gogineni, Nandipur Kallappa Dilip, Jacob Mathew, Nikhil Kaushik, Vineeth Gururaj Kulkarni.
- Deepak Mohan
- Sunil Attavar Cajaten
- Ann Valerie Sunil Attavar
- Srinivas Gogineni
- Nandipur Kallappa Dilip
- Jacob Mathew
- Nikhil Kaushik
- Vineeth Gururaj Kulkarni
What is the registered address of Grouppharma?
As per Ministry of Corporate Affairs (MCA), the registered address of Grouppharma is W-46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, 401506, India.
What is the official website of Grouppharma?
The official website of Grouppharma is https://grouppharma.in.
What is the ROC code of Grouppharma?
Grouppharma ROC code is Roc Mumbai.
What is the company classification of Grouppharma?
Grouppharma is classified as Public Limited Indian Non-Government Company.
Grouppharma - is it listed or unlisted?
Grouppharma is a Unlisted company.
What is the current status of Grouppharma?
Grouppharma is currently Active and registered in Thane, Maharashtra, India.
What industry or business activity is Grouppharma associated with?
Grouppharma lists activity aligned with: Pharma - Drug Formulation & Development - Manufacturing. See the Overview and Competition sections for fuller industry context.
How many employees does Grouppharma have?
Available records indicate roughly 739 employees for Grouppharma. Confirm against filings and EPFO-related signals on the profile where shown.
Does Grouppharma have GST registrations on file?
Grouppharma shows 2 active GST registration signal(s) in compliance overview data. Open the Compliance tab for GSTIN and filing context when your plan allows.
Where can I see charges and lenders for Grouppharma?
Use the Charges tab for MCA charge filings, charge holders, and open versus satisfied charges for Grouppharma.
How do I contact Grouppharma?
Use the official website at https://grouppharma.in and the registered office address on this profile for corporate contact. Infyner does not publish personal customer-care numbers unless they appear in sourced company records.
What is the turnover or revenue of Grouppharma?
Turnover and revenue appear in filed financial statements when available. Open the Financial tab on this profile for revenue, profit or loss, balance sheet metrics, and related MCA filings - not headline estimates.
How can I get the financial details of Grouppharma?
You can view revenue, profit or loss, balance sheet metrics, and related filings on the Financial tab of this company profile.
What is the net worth of Grouppharma (last filed snapshot)?
As per the latest financial snapshot on file for FY 2024, net worth is about ₹ 57.78 Cr. Verify figures on the Financial tab and supporting filings.
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
